Tracking pre-seed and seed rounds that close in India every week
Links out to the the websites of the startup and its investors, along with LinkedIn profiles of the founders and fundraising news.
Neuroscience startup which enables greater precision in the diagnosis and treatment planning of neuro-oncological and neuropsychiatric disorders. Provides clinicians an fMRI processing engine and machine-learning models; and a patient care app. In India, now looking at US market entry. $5M raised in this Pre-Series A round, with $925K raised earlier from Pfizer.
Gen-AI driven SaaS to manage healthcare insurance claims. Targeting a global customer base. Claims generation, processing and fraud detection, along with a suite of other solutions for hospitals and insurers. ₹5CR raised in this seed round.
AI agents to reduce administrative tasks faced by healthcare providers in the US, a lot of which continue to be manual processes faced by both the providers as well as their patients. Confido part automates tasks such as appointments, payments and pre and post operative engagement. $3M raised in this seed round.
Allogeneic Cell & Gene Therapy (CGT) startup, developing affordable and quality access to curative cell therapies for patients in India and the rest of the world. Fundraise towards setting up an FDA-standard manufacturing facility and entering Phase I trials. $4.2M raised in this seed round.
Pharma startup developing affordable, novel small-molecule targeted therapies leveraging AI. Therapies target GLP-1 and GIP receptors for Cardio-metabolic (CM) diseases, with an emphasis on diabetes and obesity. Angel round, amount undisclosed.
Healthcare diagnostics startup. Developing a device and AI based software that provides blood sample results in under ten minutes. $700K raised in this round.
AI driven mental health and wellness platform. Targets individuals and corporates who can measure, manage and improve their wellness and engagement. ₹1CR raised in pre-seed funding.
Uses nanorobots in dentistry to solve for tooth decay. Has developed two devices, for use by dentists (B2B) as well as a toothbrush-like device to be available over the counter (B2C). Funds to be used towards a manufacturing facility and aiming at clinical trials in 2025. Raised $1.2M in this seed round at a valuation of $7.1M. Incubated at IISC.
Dermatology and hair transplant services, with 15 centres in India and the UAE. ₹15CR raised in this seed round.
Consultations and live courses to teach parents in India and the US about nutrition management and introducing real food for infants. $108K pre-seed raised this November, following a $100K raise in January 2024. Angel round.